The financial implications of different deal structures is greatly enhanced through rigorous analysis of forecasts and risks. Risk and sensitivity analysis: What factors have most effect on the value of a deal? How can we reduce risk? Investing in Biotechnology: Financial Perspectives and Evaluation Strategies. Valuation continues to be one of the toughest challenges for investors and companies who are interested in forming strategic alliances or in pursuing mergers and acquisitions. Explaining market valuation by new methods and models including the DCF model and ROV (Real Options Valuation), this report covers the concepts and applications to help the biotechnology industry get to grips with the finance industry.

 

 

Home

Services

Methods

Case Studies

Contact

 

Contact

US OFFICE

SG Systems

6072 Carversville Road

PO BOX 121

Carversville PA 18913-0121
 

 

The financial implications of different deal structures is greatly enhanced through rigorous analysis of forecasts and risks. Risk and sensitivity analysis: What factors have most effect on the value of a deal? How can we reduce risk? Investing in Biotechnology: Financial Perspectives and Evaluation Strategies. Valuation continues to be one of the toughest challenges for investors and companies who are interested in forming strategic alliances or in pursuing mergers and acquisitions. Explaining market valuation by new methods and models including the DCF model and ROV (Real Options Valuation), this report covers the concepts and applications to help the biotechnology industry get to grips with the finance industry.
 

 

Copyright SG Systems, all rights reserved.

Web site design, code, and hosting by Gunkie